*Dr. Fauci's pushing an apparently worthless drug, to upstage hydroxychloroquine, and * *make **way for that vaccine without which we won't be allowed out into the world (if any).*
*MCM* 8,265 views|May 26, 2020,02:08pm EDT Remdesivir Revealed https://www.forbes.com/sites/williamhaseltine/2020/05/26/remdesivir-revealed-what-the-finally-released-data-tells-us/ [image: image.jpeg] <https://www.forbes.com/sites/williamhaseltine/> William A. Haseltine <https://www.forbes.com/sites/williamhaseltine/> Contributor Healthcare <https://www.forbes.com/healthcare> - - - [image: Maker Of Coronavirus Trial Drug Remdesivir, Gilead Sciences. Inc., Reports Positive Data Coming From Trials] FOSTER CITY, CALIFORNIA - APRIL 29: A sign is posted in front of the Gilead Sciences headquarters on ... [+] GETTY IMAGES The full data from the remdesivir trial by the National Institutes of Health (NIH) has finally been released <https://www.nejm.org/doi/full/10.1056/NEJMoa2007764>, weeks after preliminary results <https://www.nih.gov/news-events/news-releases/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19> were shared via press release. Those early results generated a great deal of hype and a world wide stampede for the drug. But the release of the full data tells a different story. The conclusion of the NIH study, published in *The New England Journal of Medicine, *states: *“These preliminary findings support the use of remdesivir for patients who are hospitalized with Covid-19 and require supplemental oxygen therapy. However, given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient. Future strategies should evaluate antiviral agents in combination with other therapeutic approaches or combinations of antiviral agents to continue to improve patient outcomes in Covid-19.”* There are a few problems this paragraph highlights. First, by opening with a reference to the data “preliminary findings” the authors are acknowledging the fact that this is not a definitive study. How could it be with such scant data? Ideally, this NIH trial and other remdesivir trials would continue to gather evidence to support the findings. But the NIH controversially ended <https://www.statnews.com/2020/05/11/inside-the-nihs-controversial-decision-to-stop-its-big-remdesivir-study/> their large trial of the drug and Gilead has suspended smaller trials <https://www.biospace.com/article/gilead-shutters-covid-19-trial-in-china-stocks-drop-3-percent-/>. More study of the drug will still be conducted through the WHO Solidarity Trial <https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments> and the Inserm DisCoVeRy Trial <https://clinicaltrials.gov/ct2/show/NCT04315948>, so there is at least a glimmer of hope that we will eventually have robust and transparent data that shows the true impact of the drug on viral load. *Click on the link for the rest.* -- If you appreciate News From Underground, please consider making a donation — either a one-time gift or a monthly subscription: http://markcrispinmiller.com/support/ Thank you for your support. Ways to unsubscribe: 1) send a blank email to [email protected] PLEASE NOTE: you must unsubscribe using the SAME email with which you subscribed 2) go to http://groups.google.com/group/newsfromunderground and click on the "Unsubscribe or change membership" link in the yellow bar at the top of the page, then click the "Unsubscribe" button on the next page. For more News From Underground, visit http://markcrispinmiller.com --- You received this message because you are subscribed to the Google Groups "News From Underground" group. To unsubscribe from this group and stop receiving emails from it, send an email to [email protected]. To view this discussion on the web visit https://groups.google.com/d/msgid/newsfromunderground/CAGxB6W_t1DcbT_6bdegn152Fd%3D1o%2BfC%3DFzr_%3D4VfA7fF%2BG%3DAUA%40mail.gmail.com.
